CAS No.
[10405-02-4(unlabelled)]
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Yes -Refer MSDS for accurate information
Trospium-d8 Chloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Trospium-d8 Chloride usage and description
Trospium-d8 chloride is a deuterated form of trospium chloride, which is an antimuscarinic drug used for the treatment of overactive bladder syndrome. Trospium-d8 chloride is used as a reference standard in the analysis of trospium chloride in biological fluids.
The chemical formula of trospium-d8 chloride is C25H34D8ClNO3, and its molecular weight is 437.09 g/mol. It is a white to off-white powder that is soluble in water and ethanol.
Trospium-d8 chloride works by blocking the muscarinic receptors in the bladder, which reduces the contractions of the bladder muscles and decreases the urge to urinate. It has a rapid onset of action and a long duration of effect.
Trospium-d8 chloride is typically administered orally, with a recommended dose of 20 mg per day. It is metabolized in the liver, and its elimination half-life is approximately 20 hours.
Some of the common side effects of trospium-d8 chloride include dry mouth, constipation, blurred vision, and dizziness. It is contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma.
In conclusion, trospium-d8 chloride is a useful tool in the analysis of trospium chloride and its pharmacokinetics. It is a safe and effective treatment option for overactive bladder syndrome when used under the guidance of a healthcare professional.
